Journal of Virology, September 1998, p. 6997-7004, Vol. 72, No. 9
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Iconix Pharmaceuticals,
Received 11 February 1998/Accepted 22 May 1998
Human cytomegalovirus (HCMV) lytic-phase DNA replication initiates
at the cis-acting origin of replication, oriLyt. oriLyt is
a structurally complex region containing repeat elements and transcription factor binding sites. We identified two site-specific alkali-labile regions within oriLyt which flank an alkali-resistant DNA
segment. These alkali-sensitive regions were the result of the
degradation of two RNA species embedded within oriLyt and covalently
linked to viral DNA. The virus-associated RNA, vRNA, was identified by
DNase I treatment of HCMV DNA obtained from sucrose gradient purified
virus. This heterogeneous population of vRNA was end labeled and used
as a hybridization probe to map the exact location of vRNAs within
oriLyt. vRNA-1 is localized between restriction endonuclease sites
XhoI at nucleotide (nt) 93799 and SacI at nt
94631 and is approximately 500 bases long. The second vRNA, vRNA-2,
lies within a region which exhibits a heterogeneous restriction pattern
located between the SphI (nt 92636) and BamHI
(nt 93513) and is approximately 300 bases long. This region was
previously shown to be required for oriLyt replication (D. G. Anders, M. A. Kacica, G. S. Pari, and S. M. Punturieri, J. Virol. 66:3373-3384, 1992). RNase H analysis determined that vRNA-2 forms a persistent RNA-DNA hybrid structure in the context of
the viral genome and in an oriLyt-containing plasmid used in the
transient-replication assay.
Reno, Reno, Nevada
895574
*
Corresponding author. Mailing address: Dept. of
Microbiology, School of Medicine, University of Nevada
Reno, Reno, NV
89557. Phone: (702) 784-1383.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|